Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Melanoma-associated antigen peptides are short amino acid sequences derived from proteins that are highly expressed in melanoma cells. These peptides can be presented on the cell surface by MHC molecules, making them recognizable targets for T cells. Key families include MAGE and HMW-MAA. They are used in cancer immunotherapy to stimulate anti-tumor immunity and can serve as diagnostic markers.
Stimulation of anti-tumor T-cell responses, antibody-mediated targeting of tumor cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Melanoma-associated Antigen Peptide (MAA Peptide).